Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

851
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

360
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

505
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

896
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
896

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies: Phenotype, Genotype, and Outcome.

Neurology·2026
Same author

Characterizing the frequency of clinical events and assessing biomarkers in propionic acidemia: a natural history study.

Orphanet journal of rare diseases·2026
Same author

Global Longitudinal Strain Alteration of the Left Ventricle in Children with Organic Aciduria: Cardiac Disease in Organic Aciduria.

Journal of clinical medicine·2026
Same author

Metachromatic leukodystrophy (MLD) in France: the views of family caregivers on the diagnosis of the disease, its daily burden on their child, and the whole family.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same author

From variant interpretation to structural discovery: A new Zinc-binding domain in PARS2.

Mitochondrion·2026
Same author

Mitochondrial Leigh syndrome: the state of the art.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2025

Related Experiment Video

Updated: Apr 15, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.7K

[Pediatric medicine in 2013].

Brigitte Chabrol

    Bulletin De L'Academie Nationale De Medecine
    |March 26, 2015
    PubMed
    Summary

    Effective pediatric patient care requires recognizing children as developing individuals within families. Management strategies must prioritize collaborative networks, preventive health, and addressing diverse health needs for long-term public health benefits.

    Area of Science:

    • Pediatric Healthcare Management
    • Child Development and Vulnerability
    • Public Health

    Context:

    • Children are unique developing individuals within family systems.
    • Current healthcare practices require adaptation for pediatric patients.
    • The long-term health outcomes of adults are influenced by childhood health.

    Purpose:

    • To outline essential considerations for managing pediatric patients.
    • To emphasize the importance of a holistic approach in pediatric care.
    • To advocate for resource allocation commensurate with pediatric health objectives.

    Summary:

    • Healthcare organization must prioritize collaborative networks.
    • Preventive actions and screening programs aim to protect individual children and improve overall public health.

    More Related Videos

    Guidelines for Elective Pediatric Fiberoptic Intubation
    11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    19.0K
    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
    06:15

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

    Published on: March 6, 2019

    53.0K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter
    10:02

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter

    Published on: December 19, 2017

    15.7K
    Guidelines for Elective Pediatric Fiberoptic Intubation
    11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    19.0K
    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
    06:15

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

    Published on: March 6, 2019

    53.0K
  • Management encompasses common diseases, chronic conditions, disabilities, and lifestyle-related issues.
  • Addressing the needs of children, families, and professionals is crucial.
  • Specific pediatric research and knowledge dissemination are vital.

    • Impact:

    • Improved health outcomes for children and future adults.
    • Enhanced public health through effective pediatric interventions.
    • Strengthened healthcare systems through collaborative networks and targeted research.